Skip to main content
Caplight Logo









Corveus Medical

Corveus Medical

Private
Houston, TexasHealthcare & Life Scienceshttps://www.corveusmedical.com/

Last Round

Accelerator

Aug 30, 2024

Est. Valuation

$1.79M

Total Funding Raised

$1.19M

Company Overview

Corveus Medical is a medical device company developing a catheter-based solution for treating chronic heart failure through a minimally-invasive nerve ablation procedure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

heart failure treatmentnerve ablationcongestive heart failuremedical devicecatheter ablationCHFminimally-invasive proceduresympathetic denervationcardiac neuromodulationinterventional cardiologycardiovascular deviceelectrophysiologyEPpre-clinical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corveus Medical Comparables

Compare Corveus Medical with similar companies based on industry and business-model similarity.

Corveus Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axon Therapies
89%
Catheter Precision, Inc.
77%
Alleviant Medical
74%

Corveus Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 30, 2024
GrantJun 1, 2023
GrantMar 1, 2023
AcceleratorJun 7, 2022
SeedJan 1, 2022

Key People

Founding team and executive leadership

Tyler Melton

CEO And Co-Founder

Founding Team

Corveus Medical Investors

Notable investors and investment history

Corveus Medical investors
InvestorRounds
MedTech InnovatorAccelerator
Texas New Venture CompetitionGrant
Y CombinatorSeed
Fogarty InnovationAccelerator, Seed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2026

    Grew 75% QoQ, from 4 to 7 employees.

  • Jun 1, 2023

    $35K grant awarded by Texas New Venture Competition.

Corveus Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Corveus Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Corveus Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range5
Year Founded2021
Last FundingAug 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?